These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20712994)

  • 41. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
    Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
    Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms of IhERG/IKr Modulation by α1-Adrenoceptors in HEK293 Cells and Cardiac Myocytes.
    Urrutia J; Alday A; Gallego M; Malagueta-Vieira LL; Aréchiga-Figueroa IA; Casis O; Sánchez-Chapula JA
    Cell Physiol Biochem; 2016; 40(6):1261-1273. PubMed ID: 27997898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides.
    Spector PS; Curran ME; Keating MT; Sanguinetti MC
    Circ Res; 1996 Mar; 78(3):499-503. PubMed ID: 8593709
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional interaction between extracellular sodium, potassium and inactivation gating in HERG channels.
    Mullins FM; Stepanovic SZ; Gillani NB; George AL; Balser JR
    J Physiol; 2004 Aug; 558(Pt 3):729-44. PubMed ID: 15169846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural determinants and biophysical properties of HERG and KCNQ1 channel gating.
    Tristani-Firouzi M; Sanguinetti MC
    J Mol Cell Cardiol; 2003 Jan; 35(1):27-35. PubMed ID: 12623297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sulfonylurea and K(+)-channel opener sensitivity of K(ATP) channels. Functional coupling of Kir6.2 and SUR1 subunits.
    Koster JC; Sha Q; Nichols CG
    J Gen Physiol; 1999 Aug; 114(2):203-13. PubMed ID: 10435998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.
    Anderson CL; Delisle BP; Anson BD; Kilby JA; Will ML; Tester DJ; Gong Q; Zhou Z; Ackerman MJ; January CT
    Circulation; 2006 Jan; 113(3):365-73. PubMed ID: 16432067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of rat erg1, erg2, erg3 and HERG K+ currents by thyrotropin-releasing hormone in anterior pituitary cells via the native signal cascade.
    Schledermann W; Wulfsen I; Schwarz JR; Bauer CK
    J Physiol; 2001 Apr; 532(Pt 1):143-63. PubMed ID: 11283231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flunarizine is a highly potent inhibitor of cardiac hERG potassium current.
    Trepakova ES; Dech SJ; Salata JJ
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):211-20. PubMed ID: 16495758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of the HERG K+ channel by the antifungal drug ketoconazole depends on channel gating and involves the S6 residue F656.
    Ridley JM; Milnes JT; Duncan RS; McPate MJ; James AF; Witchel HJ; Hancox JC
    FEBS Lett; 2006 Apr; 580(8):1999-2005. PubMed ID: 16542653
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential mechanisms for the enhancement of HERG K+ channel function by phospholipid metabolites.
    Wang J; Zhang Y; Wang H; Han H; Nattel S; Yang B; Wang Z
    Br J Pharmacol; 2004 Feb; 141(4):586-99. PubMed ID: 14744814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanistic insight into human ether-à-go-go-related gene (hERG) K+ channel deactivation gating from the solution structure of the EAG domain.
    Muskett FW; Thouta S; Thomson SJ; Bowen A; Stansfeld PJ; Mitcheson JS
    J Biol Chem; 2011 Feb; 286(8):6184-91. PubMed ID: 21135103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The HERG K+ channel: progress in understanding the molecular basis of its unusual gating kinetics.
    Vandenberg JI; Torres AM; Campbell TJ; Kuchel PW
    Eur Biophys J; 2004 Apr; 33(2):89-97. PubMed ID: 13680209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phosphatidylinositol 4,5-bisphosphate and intracellular pH regulate the ROMK1 potassium channel via separate but interrelated mechanisms.
    Leung YM; Zeng WZ; Liou HH; Solaro CR; Huang CL
    J Biol Chem; 2000 Apr; 275(14):10182-9. PubMed ID: 10744702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation properties of Kv4.3 channels: time, voltage and [K+]o dependence.
    Wang S; Bondarenko VE; Qu Y; Morales MJ; Rasmusson RL; Strauss HC
    J Physiol; 2004 Jun; 557(Pt 3):705-17. PubMed ID: 15004209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ceramide modulates HERG potassium channel gating by translocation into lipid rafts.
    Ganapathi SB; Fox TE; Kester M; Elmslie KS
    Am J Physiol Cell Physiol; 2010 Jul; 299(1):C74-86. PubMed ID: 20375276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The evolutionarily conserved residue A653 plays a key role in HERG channel closing.
    Stepanovic SZ; Potet F; Petersen CI; Smith JA; Meiler J; Balser JR; Kupershmidt S
    J Physiol; 2009 Jun; 587(Pt 11):2555-66. PubMed ID: 19406877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Open channel block of HERG K(+) channels by vesnarinone.
    Kamiya K; Mitcheson JS; Yasui K; Kodama I; Sanguinetti MC
    Mol Pharmacol; 2001 Aug; 60(2):244-53. PubMed ID: 11455010
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Norpropoxyphene-induced cardiotoxicity is associated with changes in ion-selectivity and gating of HERG currents.
    Ulens C; Daenens P; Tytgat J
    Cardiovasc Res; 1999 Dec; 44(3):568-78. PubMed ID: 10690289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dynamic partnership between KCNQ1 and KCNE1 and influence on cardiac IKs current amplitude by KCNE2.
    Jiang M; Xu X; Wang Y; Toyoda F; Liu XS; Zhang M; Robinson RB; Tseng GN
    J Biol Chem; 2009 Jun; 284(24):16452-16462. PubMed ID: 19372218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.